Francesca Carubbi
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 27, 2026
Glucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease.Francesca Carubbi, Silvia Linari, Marco Spada
|Oct 06, 2024
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease.Irene Motta, Paola Delbini, Natalia Scaramellini
|Oct 13, 2021
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis.Carla Greco, Fabio Nascimbeni, Francesca Carubbi
|Oct 22, 2020
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease.Fabio Nascimbeni, Simonetta Lugari, Pietro Andreone
|Aug 19, 2020
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease.Fabio Nascimbeni, Simonetta Lugari, Elena Cassinerio
Pageof 1
Frequent Collaborators
4 joint publications
Fabio Nascimbeni
3 joint publications
Pietro Andreone
1 joint publications
Carla Greco
1 joint publications
Manuela Simoni
1 joint publications
Daniele Santi
1 joint publications
Irene Motta
1 joint publications
Natalia Scaramellini
1 joint publications
Viola Ghiandai
1 joint publications
Lorena Duca
1 joint publications
Dario Consonni
